CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...
News Medical on MSN5d
First U.S. trial uses non-viral CRISPR to correct sickle cell mutationUCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...
UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...
This study presents important findings on cold tolerance shared between hibernating and non-hibernating mammals, identifying a key molecule, GPX4, through multi-species genome-wide CRISPR screens. The ...
Memorial Sloan Kettering Cancer Center-led researchers have identified a small molecule called gliocidin that kills ...
The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...
A laboratory cultivating cells for the development of gene and cell therapies. CRISPR Therapeutics AG (NASDAQ:CRSP) is a gene ...
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.
如今，在一项新的研究中，洛克菲勒大学细菌学实验室的Luciano Marraffini及其团队和纪念斯隆-凯特琳癌症中心结构生物学实验室的Dinshaw Patel及其团队发现一种CRISPR系统不仅能用基因剪刀对付入侵者，还能充当某种分子熏蒸剂。相关研究结果近期发表在 Cell 期刊上，论文标题为 “The CRISPR-associated adenosine deaminase Cad1 ...
Cell-to-cell communication through nanosized particles, working as messengers and carriers, can now be analyzed in a whole ...
UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 ...
2024 — A new approach for delivering miniature research tools into the interior of egg cells and embryos has been developed, resolving a major bottleneck to ... CRISPR/Cas9 Modifies Euglena to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback